The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome

Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes: Results From a Long-Term Prospective Study

(2012) A. Gambineri et al.   DIABETES

Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

(2012) Christos Vosnakis et al.   GYNECOLOGICAL ENDOCRINOLOGY

The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis

(2012) S. S. Lim et al.   Obesity Reviews

Orlistat accentuates the fat-induced fall in blood pressure in older adults

(2011) Kamilia Tai et al.   BRITISH JOURNAL OF NUTRITION

Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome

(2011) Sarantis Livadas et al.   CLINICAL ENDOCRINOLOGY

Low HDL predicts differential blood pressure effects from two weight-loss approaches: a secondary analysis of blood pressure from a randomized, clinical weight-loss trial

(2011) C. B. Turer et al.   DIABETES OBESITY & METABOLISM

Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial

(2011) Elisabet Stener-Victorin et al.   FERTILITY AND STERILITY

The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study

(2011) Sedigheh Ghandi et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

(2011) Mark O. Goodarzi et al.   Nature Reviews Endocrinology

High-density lipoprotein metabolism and endothelial function

(2011) Charles J Lowenstein et al.   Current Opinion in Endocrinology Diabetes and Obesity

Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial

(2010) S. Palomba et al.   HUMAN REPRODUCTION

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians

(2009) Y. M. Jeanes et al.   JOURNAL OF HUMAN NUTRITION AND DIETETICS

Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome

(2009) A. Gambineri et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome

(2008) L. W. Cho et al.   CLINICAL ENDOCRINOLOGY

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society

(2008) Lisa J. Moran et al.   FERTILITY AND STERILITY

An RCT of metformin versus orlistat for the management of obese anovulatory women

(2008) M. Metwally et al.   HUMAN REPRODUCTION

Consensus on infertility treatment related to polycystic ovary syndrome

(2008)   HUMAN REPRODUCTION

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation

(2008) Leslee J. Shaw et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome

(2008) Rebecca L. Thomson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels

(2007) Dimitrios Panidis et al.   FERTILITY AND STERILITY